New paper is published!

Dr. Kawakita published her latest finding in the Journal of Virology

Kawakita, T., Sekiya, T., Kameda, Y., Nomura, N., Ohno, M., Handabile, C., Yamaya, A., Fukuhara, H., Anraku, Y., Kita, S., Toba, S., Tsukamoto, H., Sawa, T., Oshiumi, H., Itoh, Y., Maenaka, K., Sato, A., Sawa, H., Suzuki, Y., Brown, L. E., Jackson, D. C., Kida, H., Matsumoto, M., & Seya, T. (2025). ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction. Journal of Virology. https://doi.org/10.1128/jvi.02290-24